lactic acid has been researched along with ganciclovir in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 11 (64.71) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Herrero-Vanrell, R; Refojo, MF; Veloso, AA; Zhu, Q | 1 |
Hashizoe, M; Honda, Y; Ikada, Y; Kunou, N; Ogura, Y; Takanashi, T | 1 |
Fernandez-Carballido, A; Herrero-Vanrell, R; Ramirez, L; Refojo, MF | 1 |
Kunou, N; Matsuda, Y; Nakajima, K; Ogura, Y; Ozeki, H; Sakurai, E | 1 |
Kimura, H; Ogura, Y; Tabata, Y; Yasukawa, T | 1 |
Beraza, N; Bustos, M; Herraiz, M; Montoya, J; Prieto, J; Qian, C; Sangro, B; Solano, A | 1 |
He, Q; Liu, J; Xu, CQ; Zhang, ZR | 1 |
Duvvuri, S; Janoria, KG; Mitra, AK | 1 |
Duvvuri, S; Gaurav Janoria, K; Mitra, AK | 1 |
Carmichael, T; Choonara, YE; Danckwerts, MP; Pillay, V | 1 |
Janoria, KG; Mitra, AK | 1 |
Duvvuri, S; Janoria, KG; Mitra, AK; Pal, D | 1 |
Chen, X; Ooi, CP | 1 |
Carmichael, TR; Choonara, YE; Danckwerts, MP; Du Toit, LC; Meyer, LC; Naylor, S; Pillay, V; Wanblad, C | 1 |
Agrahari, V; Mitra, AK; Pal, D; Shah, SJ; Wang, Z; Yang, X | 1 |
Shen, Y; Sun, C; Tu, J; Wang, Q; Xu, B | 1 |
1 review(s) available for lactic acid and ganciclovir
Article | Year |
---|---|
Biodegradable scleral plugs for vitreoretinal drug delivery.
Topics: Animals; Biodegradation, Environmental; Cytomegalovirus Retinitis; Drug Delivery Systems; Eye Diseases; Ganciclovir; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Retinal Diseases; Sclera; Solubility; Vitreoretinopathy, Proliferative; Vitreous Body | 2001 |
16 other study(ies) available for lactic acid and ganciclovir
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus.
Topics: Animals; Antigens, Viral; Biocompatible Materials; Biodegradation, Environmental; Cytomegalovirus; Cytomegalovirus Retinitis; Disease Models, Animal; Drug Delivery Systems; Eye Diseases; Female; Fluorescent Antibody Technique, Indirect; Ganciclovir; Humans; Lactic Acid; Male; Microspheres; Optic Neuritis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Virus Cultivation; Vitreous Body | 1997 |
Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.
Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Ganciclovir; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prostheses and Implants; Rabbits; Vitreous Body | 1997 |
Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Topics: Antiviral Agents; Biocompatible Materials; Capsules; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Administration Routes; Drug Carriers; Drug Stability; Gamma Rays; Ganciclovir; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Sterilization; Vitreous Body | 2000 |
Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis.
Topics: Absorbable Implants; Animals; Antigens, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Implants; Fluorescent Antibody Technique, Indirect; Ganciclovir; Humans; Lactic Acid; Male; Molecular Weight; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Sclera; Vitreous Body | 2001 |
Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion.
Topics: Adenoviridae; Alanine Transaminase; Animals; Antigens, Tumor-Associated, Carbohydrate; Aspartate Aminotransferases; DNA, Mitochondrial; Electron Transport Complex IV; Ganciclovir; Genetic Vectors; HeLa Cells; Herpesvirus 1, Human; Humans; Lactic Acid; Liver Failure; Male; Mitochondria; Rats; Rats, Wistar; RNA; RNA, Mitochondrial; Thymidine Kinase; Tumor Cells, Cultured | 2003 |
[Study on the preparation of TK-gene nanoparticles and its expression].
Topics: alpha-Fetoproteins; Biocompatible Materials; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Ganciclovir; Genes, Reporter; Green Fluorescent Proteins; Herpesvirus 1, Human; Humans; Lactic Acid; Liver; Liver Neoplasms; Luminescent Proteins; Nanotechnology; Particle Size; Plasmids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Recombinant Proteins; Thymidine Kinase; Transfection | 2004 |
Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Topics: Algorithms; Antiviral Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Compounding; Excipients; Ganciclovir; Gels; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface Properties | 2005 |
Effect of polymer blending on the release of ganciclovir from PLGA microspheres.
Topics: Algorithms; Antiviral Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Ganciclovir; Lactic Acid; Microspheres; Models, Statistical; Nonlinear Dynamics; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Regression Analysis | 2006 |
An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation.
Topics: Anti-Retroviral Agents; Aqueous Humor; Drug Carriers; Drug Implants; Eye; Foscarnet; Ganciclovir; Hardness; Humans; In Vitro Techniques; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Tablets; Viscosity | 2006 |
Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Topics: Delayed-Action Preparations; Ganciclovir; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prodrugs; Solubility | 2007 |
Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Chemistry, Pharmaceutical; Cytomegalovirus Retinitis; Delayed-Action Preparations; Ganciclovir; Gels; Half-Life; Lactic Acid; Male; Microdialysis; Microspheres; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Retina; Temperature; Tissue Distribution; Vitreous Body | 2007 |
Hydrolytic degradation and drug release properties of ganciclovir-loaded biodegradable microspheres.
Topics: Buffers; Drug Delivery Systems; Ganciclovir; Glass; Glycolates; Hydrogen-Ion Concentration; Hydrolysis; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protons; Time Factors; Transition Temperature | 2008 |
In vivo evaluation of a biodegradable donut-shaped minitablet for prolonged posterior segment drug delivery in the rabbit eye model.
Topics: Absorbable Implants; Animals; Antiviral Agents; Delayed-Action Preparations; Drug Delivery Systems; Equipment Design; Ganciclovir; Hydrogen-Ion Concentration; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Posterior Eye Segment; Rabbits | 2011 |
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Topics: Administration, Ophthalmic; Delayed-Action Preparations; Dipeptides; Drug Delivery Systems; Emulsions; Eye Diseases; Ganciclovir; Gels; Lactic Acid; Microspheres; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs | 2016 |
Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment.
Topics: 4-Butyrolactone; Animals; Antiviral Agents; Aqueous Humor; Area Under Curve; Biocompatible Materials; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Ganciclovir; Hydrogels; Lactic Acid; Male; Polyethylene Glycols; Polymers; Rabbits; Temperature | 2018 |